Sofosbuvir-ribavirin combo shows promise for hepatitis C

04/24/2013 | HealthDay News

A study found that combining hepatitis C treatment sofosbuvir with ribavirin for patients who cannot take interferon led to a 78% cure rate three months into treatment. In patients unresponsive to interferon, the study documented a 73% cure rate after four months of treatment with combination therapy. Another study found similar cure rates of 67% for treatment with either sofosbuvir and ribavirin or ribavirin and interferon.

View Full Article in:

HealthDay News

Published in Brief: